Monroe Capital Corporation
Monroe Capital Corporation (MRCC) Financial Performance & Income Statement Overview
Analyze Monroe Capital Corporation (MRCC) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Monroe Capital Corporation (MRCC) Income Statement & Financial Overview
View the income breakdown for Monroe Capital Corporation MRCC across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $9.46M | -$461000.00 | $12.13M | $16.13M |
| Cost of Revenue | $6.53M | $0.00 | $0.00 | $2.64M |
| Gross Profit | $2.93M | -$461000.00 | $12.13M | $13.49M |
| Gross Profit Ratio | $0.31 | $1.00 | $1.00 | $0.84 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $226000.00 | $760000.00 | $825000.00 | $765000.00 |
| Operating Expenses | $904000.00 | -$461000.00 | $9.08M | $8.93M |
| Total Costs & Expenses | $7.43M | -$461000.00 | $9.08M | $6.96M |
| Interest Income | $8.48M | $12.50M | $10.41M | $14.35M |
| Interest Expense | $4.68M | $4.78M | $5.18M | $5.45M |
| Depreciation & Amortization | $0.00 | $0.00 | $0.00 | -$12.47M |
| EBITDA | $8.88M | $0.00 | $0.00 | $0.00 |
| EBITDA Ratio | $0.94 | $0.00 | $0.00 | $0.00 |
| Operating Income | $2.03M | $0.00 | $3.06M | $12.47M |
| Operating Income Ratio | $0.21 | $0.00 | $0.25 | $0.77 |
| Other Income/Expenses (Net) | $2.18M | -$1.55M | $2.04M | -$9.08M |
| Income Before Tax | $4.21M | -$1.55M | $5.10M | $3.39M |
| Income Before Tax Ratio | $0.44 | $3.37 | $0.42 | $0.21 |
| Income Tax Expense | $120000.00 | $163000.00 | $136000.00 | $135000.00 |
| Net Income | $4.09M | -$1.72M | $4.97M | $3.26M |
| Net Income Ratio | $0.43 | $3.72 | $0.41 | $0.20 |
| EPS | $0.19 | -$0.08 | $0.23 | $0.15 |
| Diluted EPS | $0.19 | -$0.08 | $0.23 | $0.15 |
| Weighted Avg Shares Outstanding | $21.67M | $21.67M | $21.67M | $21.67M |
| Weighted Avg Shares Outstanding (Diluted) | $21.67M | $21.67M | $21.67M | $21.67M |
The company's financials show resilient growth, with revenue advancing from $16.13M in Q2 2024 to $9.46M in Q1 2025. Gross profit remained healthy with margins at 31% in Q1 2025 compared to 84% in Q2 2024. Operating income hit $2.03M last quarter, sustaining a consistent 21% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $8.88M. Net income rose to $4.09M, while earnings per share reached $0.19. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan